Page 9 - Ludwig Maximilian University of Munich

Diseases, Conditions, Syndromes

New marker for better assessing the severity of COVID-19

Biomedical scientists at LMU have found a new marker in the blood of COVID-19 patients. It furnishes insights into the course and development of the disease and could lead to better diagnoses.

Diseases, Conditions, Syndromes

How COVID-19 alters the immune system

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections.

Medical research

Defining a healthy microbiome

In a new study, Bärbel Stecher and her team from LMU have shown that, depending on the composition of the microbiome, E. coli bacteria can prevent infections by Salmonella strains.

Genetics

Improved vectors for ocular gene therapy

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated ...

Medical research

Functionality of immune cells in early life

A study by LMU researchers shows that putatively immature dendritic cells found in young children are able to induce robust immune responses. The results could lead to improved vaccination protocols.

Diseases, Conditions, Syndromes

Study examines local perceptions of Chagas disease in Bolivia

A new study examines local perceptions of Chagas disease in a region where the infectious agent is endemic. The results underline the need to take social and cultural factors into account in campaigns designed to curb infectious ...

Medical research

The placebo effect meets the proteome

The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its ...

page 9 from 25